These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Changes induced in the bioelectric activity of rat subcortical nervous structures by Gerovital H3 and Aslavital as compared to procaine. Pop M; Tarba C Physiologie; 1988; 25(3):137-49. PubMed ID: 3144011 [TBL] [Abstract][Full Text] [Related]
5. A look at Gerovital--the "youth" drug. Kent S Geriatrics; 1976 Dec; 31(12):95-6, 101-2. PubMed ID: 1001903 [TBL] [Abstract][Full Text] [Related]
6. The reappearance of procaine hydrochloride (Gerovital H3) for antiaging. Perls T J Am Geriatr Soc; 2013 Jun; 61(6):1024-1025. PubMed ID: 23772727 [No Abstract] [Full Text] [Related]
7. Effects of a procaine preparation (Gerovital H3) in hospitalized geriatric patients: a double-blind study. Zwerling I; Plutchik R; Hotz M; Kling R; Rubin L; Grossman J; Siegel B J Am Geriatr Soc; 1975 Aug; 23(8):355-9. PubMed ID: 1097490 [TBL] [Abstract][Full Text] [Related]
9. Procaine. Will it keep you younger longer? Thomas R Med J Aust; 1983 Jun; 1(12):543-5. PubMed ID: 6855656 [No Abstract] [Full Text] [Related]
10. Hypersensitivity reactions to Gerovital. Förström L; Hannuksela M; Idänpään-Heikkilä J; Salo OP Dermatologica; 1977; 154(6):367-9. PubMed ID: 142033 [TBL] [Abstract][Full Text] [Related]
11. A trial of Gerovital H-3 in depression during senility. Sakalis G; Oh D; Gershon S; Shopsin B Curr Ther Res Clin Exp; 1974 Jan; 16(1):59-63. PubMed ID: 4203849 [No Abstract] [Full Text] [Related]
12. [Considerations on the influence of treatment with Gerovital H3 (lozenges) on working capacity of active persons over 45 years of age]. Untea G; Bercu G G Gerontol; 1969 Aug; 17(8):795-9. PubMed ID: 5371742 [No Abstract] [Full Text] [Related]
13. The systemic use of procaine in the treatment of the elderly: a review. Ostfeld A; Smith CM; Stotsky BA J Am Geriatr Soc; 1977 Jan; 25(1):1-19. PubMed ID: 12204 [TBL] [Abstract][Full Text] [Related]
16. The Radioprotective Effect of Procaine and Procaine-Derived Product Gerovital H3 in Lymphocytes from Young and Aged Individuals. Ungurianu A; Margina D; Borsa C; Ionescu C; von Scheven G; Oziol L; Faure P; Artur Y; Bürkle A; Gradinaru D; Moreno-Villanueva M Oxid Med Cell Longev; 2020; 2020():3580934. PubMed ID: 32685092 [TBL] [Abstract][Full Text] [Related]
17. [Electroencephalographic findings in a group of aged subjects treated with potentiated gerovital-H3]. Aslan A; Buşilă V; Sacerdoţeanu F Fiziol Norm Patol; 1968; 14(3):263-70. PubMed ID: 5686658 [No Abstract] [Full Text] [Related]
18. [Therapy with Gerovital H3 in ambulatory conditions]. Creţeanu C; Hurjui J; Bejan V; Duda R; Albu D Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):169-74. PubMed ID: 5552552 [No Abstract] [Full Text] [Related]
19. [Studies of peripheral circulation with the postural oscillometric method in a group of aged persons treated with potentiated Gerovital H]. Aslan A; Vrăbiescu A; Buşilă V Fiziol Norm Patol; 1967; 13(6):561-6. PubMed ID: 5594206 [No Abstract] [Full Text] [Related]
20. Procaine (Gerovital): no effect on the rehabilitation result in patients with back or hip disease. Rissanen V; Rissanen P; Tuomisto J Ann Med; 1990 Jun; 22(3):151-6. PubMed ID: 2203382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]